Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2010
11/25/2010WO2010081800A3 Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
11/25/2010WO2010081079A3 Composition and method for treatment of diabetes
11/25/2010WO2010080730A3 Methods and materials for delivering bile acids
11/25/2010WO2010078538A3 Enhanced carriers for the delivery of microparticles to bodily tissues and fluids
11/25/2010WO2010063995A3 Telmisartan with diuretic formulations
11/25/2010WO2010048623A3 Medical and imaging nanoclusters
11/25/2010WO2010018408A3 Pharmaceutical compositions with tetrabenazine
11/25/2010WO2009148580A3 Controlled release copolymer formulation with improved release kinetics
11/25/2010WO2009142893A3 Methods and compositions for the delivery of bioactive compounds
11/25/2010WO2009135190A3 Therapeutic calcium phosphate particles and methods of making and using same
11/25/2010WO2009023030A8 Immediate release and sustained release ibuprofen dosing regimen
11/25/2010US20100298816 Magnetic delivery device
11/25/2010US20100298758 Method for non-therapeutic or therapeutic photodynamic skin treatment
11/25/2010US20100298552 Emulsion compositions
11/25/2010US20100298435 Stable Emulsions of Oils in Aqueous Solutions and Methods for Producing Same
11/25/2010US20100298420 Compositions and Methods for Intracellular Delivery
11/25/2010US20100298266 Hydroxyethylstarch
11/25/2010US20100297263 Colon cleansing compositions and methods
11/25/2010US20100297252 Nanoparticulate meloxicam formulations
11/25/2010US20100297251 Encapsulated particles for enteric release
11/25/2010US20100297250 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
11/25/2010US20100297249 Enhancement of the efficacy of therapeutic proteins
11/25/2010US20100297248 Encapsulated particles for amorphous stability enhancement
11/25/2010US20100297247 Aqueous-Core Lipid Nanocapsules for Encapsulating Hydrophilic and/or Lipophilic Molecules
11/25/2010US20100297246 Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorptioin through modulation of nf-kb
11/25/2010US20100297245 Methods and compositions for oral administration of protein and peptide therapeutic agents
11/25/2010US20100297244 Nanodispersion
11/25/2010US20100297243 Prion free nanoparticle compositions and methods of making thereof
11/25/2010US20100297242 Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same
11/25/2010US20100297241 Amorphous Fesoterodine Fumarate
11/25/2010US20100297240 1- [2- (2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
11/25/2010US20100297239 Osseointegrative meniscus and cartilage implants based on beta-glucan nanocomposites
11/25/2010US20100297238 Multifunctional and Biologically Active Matrices from Multicomponent Polymeric Solutions
11/25/2010US20100297237 Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
11/25/2010US20100297236 Hybrid inducible release vehicle
11/25/2010US20100297234 Method of using an extracellular matrix to enhance cell transplant survival and differentiation
11/25/2010US20100297233 Oscillating cell culture bioreactor
11/25/2010US20100297232 Ondansetron film compositions
11/25/2010US20100297231 Preservation of bioactive materials by freeze dried foam
11/25/2010US20100297230 Compositions and methods for prostate and menstrual/menopausal related health
11/25/2010US20100297229 Tapentadol compositions
11/25/2010US20100297228 Universal coating for imprinting identification features
11/25/2010US20100297227 Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
11/25/2010US20100297226 Multiple unit pharmaceutical formulation
11/25/2010US20100297225 Sustained-release pharmaceutical formulation containing an antimuscarinic agent and a wetting agent as well as a process for the preparation thereof
11/25/2010US20100297224 NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use
11/25/2010US20100297223 Pharmaceutical dosage form comprising a liquid or flowable core composition
11/25/2010US20100297222 Method for production of microcapsules using solid fat
11/25/2010US20100297221 pharmaceutical composition of tacrolimus
11/25/2010US20100297220 Pharmaceutical Formulation And Method For Treating Acid-Caused Gastrointestinal Disorders
11/25/2010US20100297219 Methods and Compositions for Modifying Apolipoprotein B mRNA Editing
11/25/2010US20100297218 Tissue adhesive compositions and methods thereof
11/25/2010US20100297217 Isoprenoid compounds, their isolation and use
11/25/2010US20100297216 Method for administration of pegylated liposomal doxorubicin
11/25/2010US20100297215 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
11/25/2010US20100297214 Percolative drying for the preparation of particles
11/25/2010US20100297213 Method For Making Patches By Electrospray
11/25/2010US20100297212 Scaffold for cell growth and differentiation
11/25/2010US20100297210 Repair and treatment of bone defect using agent produced by chondrocytes capable of hypertrophication and scaffold
11/25/2010US20100297208 Scaffold
11/25/2010US20100297205 Patch for the expulsion of insect poison from the skin after stings from membranous insects (hymenoptera)
11/25/2010US20100297203 Impact of calcium phosphate complex on dental caries
11/25/2010US20100297202 Planar antenna and method of manufacturing the same
11/25/2010US20100297200 Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
11/25/2010US20100297199 Nanoemulsion of resveratrol-phospholipid complex and method for preparing the same and applications thereof
11/25/2010US20100297198 Liquid-type dentifrice composition contained silver particles and mousse-type dentifrice using the same
11/25/2010US20100297196 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
11/25/2010US20100297195 Controlled release lamotrigine formulations
11/25/2010US20100297194 Formulation for oral administration of apoptosis promoter
11/25/2010US20100297193 Methods of therapeutic treatment of eyes
11/25/2010US20100297192 Use of microparticles for vaccines and the release of biologically active molecules
11/25/2010US20100297190 Identification features
11/25/2010US20100297044 Emulsifier Mixture Containing Fatty Alcohols, Ethoxylated Fatty Alcohols and Oil or Wax Components
11/25/2010US20100297037 Material composition for oral hygiene product
11/25/2010US20100297035 Thiazole Amides, Imidazole Amides and Related Analogues
11/25/2010US20100297034 Osmolyte-containing preparation for use in case of dry mucous membranes
11/25/2010US20100297033 Megaribavirin alone or combination of other antiviral, antioxidant and a perflubron emulsion for treatment of viral disease
11/25/2010US20100297032 Transdermal delivery system
11/25/2010US20100297031 Orodispersible tablets
11/25/2010US20100297030 Composition, device, and method for treating sexual dysfunction via inhalation
11/25/2010US20100297029 Virucidal composition
11/25/2010US20100297028 Medicament combinations for the treatment of respiratory diseases
11/25/2010US20100297027 Overt authentication features for compositions and objects and methods of fabrication and verification thereof
11/25/2010US20100297019 Particles for imaging
11/25/2010US20100297009 Self-assembled polyhedral multimeric chemical structures
11/25/2010US20100297007 Ligand directed toroidal nanoparticles for therapy and diagnostic imaging
11/25/2010US20100294927 High throughput inspecting
11/25/2010US20100294268 Aerosol Generating Method and Device
11/25/2010CA2762989A1 Application and uses of prg4 and therapeutic modulation thereof
11/25/2010CA2762939A1 Self-emulsifying composition of .omega.3 fatty acid
11/25/2010CA2762551A1 Cell-penetrating peptides
11/25/2010CA2762391A1 Liquid dosage forms of isotretinoin
11/25/2010CA2762388A1 Oral compositions of celecoxib
11/25/2010CA2762336A1 Solid pharmaceutical compositions and processes for their production
11/25/2010CA2762179A1 Composition comprising oil drops
11/25/2010CA2761624A1 Compositions for continuous administration of dopa decarboxylase inhibitors
11/25/2010CA2761576A1 Oral suspension comprising telmisartan
11/25/2010CA2760750A1 Pharmaceutical compositions for n-[2-(diethylamino)ethyl]-5-[(fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide
11/25/2010CA2760130A1 Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof
11/25/2010CA2759213A1 Single-use, disposable strip for application of topical compositions
1 ... 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 ... 2991